Chronic thromboembolic pulmonary hypertension (CTEPH): Updated Recommendations of the Cologne Consensus Conference 2011

International Journal of Cardiology

Volumn 154, Issue SUPPL. 1, 2011, Pages

  Wilkens, Heinrike ^a   Lang, Irene ^b   Behr, Jürgen ^c   Berghaus, Thomas ^d   Grohe, Christian ^e   Guth, Stefan ^f   Hoeper, Marius M ^g   Kramm, Thorsten ^f   Krüger, Ulrich ^h   Langer, Frank ^a   Rosenkranz, Stephan ⁱ   Schäfers, Hans Joachim ^a   Schmidt, Matthias ^j   Seyfarth, Hans Jürgen ^k   Wahlers, Thorsten ^j   Worth, Heinrich ^l   Mayer, Eckhard ^f  

^a SAARLAND UNIVERSITY   (Germany)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

^c RUHR UNIVERSITY BOCHUM   (Germany)

^d Augsburg Hospital   (Germany)

^e Clinic for Respiratory Medicine   (Germany)

^f KERCKHOFF HEART CENTER   (Germany)

^g HANNOVER MEDICAL SCHOOL   (Germany)

^h Heart Center Duisburg   (Germany)

ⁱ UNIVERSITY OF COLOGNE   (Germany)

^j UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

^k UNIVERSITY HOSPITAL LEIPZIG   (Germany)

^l Hospital Fürth   (Germany)

more..

Author keywords

Chronic thromboembolic pulmonary; Diagnosis; hypertension; Treatment

Indexed keywords

ANTIVITAMIN K; BOSENTAN; ENDOTHELIN RECEPTOR ANTAGONIST; PHOSPHODIESTERASE V INHIBITOR; PROSTANOID;

ANGIOCARDIOGRAPHY; ANGIOSCOPY; CARDIOLOGY; CHILD HEALTH CARE; CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; CONFERENCE PAPER; CONSENSUS DEVELOPMENT; DIAGNOSTIC PROCEDURE; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; ENDARTERECTOMY; EUROPE; GERMANY; HEALTH CARE ORGANIZATION; HEALTH CARE PLANNING; HEART CATHETERIZATION; HUMAN; LUNG EMBOLISM; LUNG SCINTISCANNING; LUNG VENTILATION PERFUSION RATIO; MEDICAL SPECIALIST; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOGENESIS; PATIENT REFERRAL; PEDIATRIC CARDIOLOGY; PRACTICE GUIDELINE; PRIORITY JOURNAL; PULMONARY ENDARTERECTOMY; PULMONARY HYPERTENSION; PULMONOLOGY; RISK FACTOR; THROMBOPHILIA; TREATMENT CONTRAINDICATION; TREATMENT INDICATION; VENOUS THROMBOEMBOLISM;

CHRONIC DISEASE; HUMANS; HYPERTENSION, PULMONARY; LUNG; PULMONARY ARTERY; PULMONARY EMBOLISM; RISK FACTORS; VENTILATION-PERFUSION RATIO;

EID: 84855377058     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/S0167-5273(11)70493-4     Document Type: Conference Paper

References (43)

1. Galiè N, Hoeper MM, Humbert M, et al. Guidelines for the diagnosis and treatment of pulmonary hypertension: The Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT). Eur Heart J 2009;30:2493-2537.
2. Galie N, Hoeper MM, Humbert M, et al. Guidelines for the diagnosis and treatment of pulmonary hypertension. The task force for the diagnosis and treatment of pulmonary hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT). Eur Respir J 2009; 34:1219-63.
3. Hoeper MM, Ghofrani HA, Gorenflo M, Grünig E, Schranz D, Rosenkranz S. Diagnostik und Therapie der pulmonalen Hypertonie: Europäische Leitlinien 2009. Pneumologie 2010;64:401-14.
4. Fedullo PF, Auger WR, Kerr KM, Rubin LJ. Chronic thromboembolic pulmonary hypertension. N Engl J Med 2001;345:1465-72.
5. Lang IM. Chronic thromboembolic pulmonary hypertension - not so rare after all. N Engl J Med 2004;350:2236-8. (Pubitemid 38669205)
6. Pengo V, Lensing AW, Prins MH, Marchiori A, Davidson BL, Tiozzo F, et al. Incidence of chronic thromboembolic pulmonary hypertension after pulmonary embolism. N Engl J Med 2004;350:2257-64.
7. Becattini C, Agnelli G, Pesavento R, Silingardi M, Poggio R, Taliani MR, et al. Incidence of chronic thromboembolic pulmonary hypertension after a first episode of pulmonary embolism. Chest 2006;130:172-5. (Pubitemid 44116856)
8. Hoeper MM, Mayer E, Simonneau G, Rubin LJ. Chronic thromboembolic pulmonary hypertension. Circulation 2006;113:2011-20.
9. Torbicki A, Perrier A, Konstantinides S, et al. Guidelines on the diagnosis and management of acute pulmonary embolism: The Task Force fo the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC). Eur Heart J 2008;28:2276-2315.
10. Galiè N, Kim NHS. Pulmonary miscrovascular disease in chronic thromboembolic pulmonary hypertension. Proc Am Thorac Soc 2006;3:571-6. (Pubitemid 44411622)
11. Wolf M, Boyer-Neumann C, Parent F, Eschwege V, Jaillet H, Meyer D, et al. Thrombotic risk factors in pulmonary hypertension. Eur Respir J 2000;15:395-9. (Pubitemid 30085971)
12. Bonderman D, Turecek PL, Jakowitsch J, Weltermann A, Adlbrecht C, Schneider B, et al. High prevalence of elevated clotting factor VIII in chronic thromboembolic pulmonary hypertension. Thromb Haemost 2003;90:372-6. (Pubitemid 37138760)
13. Bonderman D, Wilkens H, Wakounig S, Schäfers HJ, Jansa P, Lindner J, et al. Risk factors for chronic thromboembolic pulmonary hypertension. Eur Respir J 2009;33:325-31.
14. Ignatescu M, Kostner K, Zorn G, Kneussl M, Maurer G, Lang IM, et al. Plasma Lp(a) levels are increased in patients with chronic thromboembolic pulmonary hypertension. Thromb Haemost 1998;80:231-2. (Pubitemid 28393614)
15. Bonderman D, Jakowitsch J, Adlbrecht C, Schemper M, Kyrle PA, Schonauer V, et al. Medical conditions increasing the risk of chronic thromboembolic pulmonary hypertension. Thromb Haemost 2005;93:512-6. (Pubitemid 40392541)
16. Jais X, Ioos V, Jardim C, Sitbon O, Parent F, Hamid A, et al. Splenectomy and chronic thromboembolic pulmonary hypertension. Thorax 2005;60:1031-4. (Pubitemid 41705472)
17. Bonderman D, Skoro-Sajer N, Jakowitsch J, Adlbrecht C, Dunkler D, Taghavi S, Klepetko W, Kneussl M, Lang IM. Predictors of outcome in chronic thromboembolic pulmonary hypertension. Circulation 2007;115:2153-8. (Pubitemid 46659067)
18. Bajc M, Neilly JB, Miniati M, Schuemichen C, Meignan M, Jonson B; EANM Committee. EANM guidelines for ventilation/perfusion scintigraphy: Part 1. Pulmonary imaging with ventilation/perfusion single photon emission tomography. Eur J Nucl Med Mol Imaging 2009;36:1356-70.
19. Bajc M, Neilly JB, Miniati M, Schuemichen C, Meignan M, Jonson B. EANM guidelines for ventilation/perfusion scintigraphy: Part 2. Algorithms and clinical considerations for diagnosis of pulmonary emboli with V/P(SPECT) and MDCT. Eur J Nucl Med Mol Imaging 2009;36:1528-38.
20. Tunariu N, Gibbs SJR, Win Z, et al. Ventilation-perfusion scintigraphy is more sensitive than multidetector CTPA in detecting chronic thromboembolic pulmonary disease as a treatable cause of pulmonary hypertension. J Nucl Med 2007;48:680-4. (Pubitemid 47604965)
21. Dartevelle P, Fadel E, Mussot S, et al. Chronic thromboembolic pulmonary hypertension. Eur Respir J 2004;23:637-48. (Pubitemid 38456010)
22. Reichelt A, Hoeper MM, Galanski M, et al. Chronic thromboembolic pulmonary hypertension: evaluation with 64-detector row CT versus digital substraction angiography. Eur J Radiol 2009;71:49-54.
23. Hoeper MM, Lee SH, Voswinckel R, et al. Complications of right heart catheterization procedures in patients with pulmonary hypertension in experienced centers. J Am Coll Cardiol 2006;48:2546-52. (Pubitemid 44881214)
24. Kreitner KF, Kunz RP, Ley S, et al. Chronic thromboembolic pulmonary hypertension-assessment by magnetic resonance imaging. Eur Radiol 2007; 17:11-21. (Pubitemid 46063024)
25. Shure D, Gregoratos G, Moser KM. Fiberoptic angioscopy: role in the diagnosis of chronic pulmonary arterial obstruction. Ann Intern Med 1985;103:844-50. (Pubitemid 16175493)
26. Skoro-Sajer N, Hack N, Sadushi-Koliçi R, Bonderman D, Jakowitsch J, Klepetko W, Hoda MA, Kneussl MP, Fedullo P, Lang IM. Pulmonary vascular reactivity and prognosis in patients with chronic thromboembolic pulmonary hypertension: a pilot study. Circulation 2009;119:298-305.
27. Kim NH, Fesler P, Channick RN, Knowlton KU, Ben-Yehuda O, Lee SH, Naeije R, Rubin LJ. Pre-operative partitioning of pulmonary vascular resistance correlates with early outcome following thromboendarterectomy for chronic thromboembolic pulmonary hypertension. Circulation 2004;109:18-22. (Pubitemid 38056014)
28. Bresser P, Fedullo PF, Auger WR, et al. Continuous intravenous epoprostenol for chronic thromboembolic pulmonary hypertension. Eur Respir J 2004;23:595-600. (Pubitemid 38456003)
29. Nagaya N, Sasaki N, Ando M, et al. Prostacyclin therapy before pulmonary thromboendarterectomy in patients with chronic thromboembolic pulmonary hypertension. Chest 2003;123:338-43. (Pubitemid 36269413)
30. Hoeper MM, Kramm T, Wilkens H, et al. Bosentan therapy for inoperable chronic thromboembolic pulmonary hypertension. Chest 2005;128:2363-7. (Pubitemid 41507580)
31. Hughes R, George P, Parameshwar J, et al. Bosentan in inoperable chronic thromboembolic pulmonary hypertension. Thorax 2005;60:707. (Pubitemid 41129077)
32. Bonderman D, Nowotny R, Skoro-Sajer N, et al. Bosentan therapy for inoperable chronic thromboembolic pulmonary hypertension. Chest 2005;128:2599-2603. (Pubitemid 41507615)
33. Reichenberger F, Voswinckel R, Enke B, et al. Long-term treatment with sildenafil in chronic thromboembolic pulmonary hypertension. Eur Respir J 2007;30:922-7. (Pubitemid 351194796)
34. Condliffe R, Kiely DG, Gibbs JS, et al. Improved outcomes in medically and surgically treated chronic thromboembolic pulmonary hypertension. Am J Respir Crit Care Med 2008;177:1122-7. (Pubitemid 351717571)
35. Seyfarth H.J., Halank M, Wilkens H, Schäfers HJ, Ewert R, Riedel M, Schuster E. Hammerschmidt S, Wirtz H. Standard PAH therapy improves long term survival in CTEPH patients. Clin Res Cardiol 2010;99:553-6.
36. Jais X, D'Armini AM, Jansa P, Torbicki A, Delcroix M, Ghofrani HA, Hoeper MM, Lang IM, Mayer E, Pepke-Zaba J, Perchenet L, Morganti A, Simonneau G, Rubin LJ. Bosentan for treatment of inoperable chronic thromboembolic pulmonary hypertension: BENEFiT (Bosentan Effects in iNopErable Forms of chronIc Thromboembolic pulmonary hypertension), a randomized, placebo-controlled trial. J Am Coll Cardiol 2008;52:2127-34.
37. Vuylsteke A, Sharples L, Charman G, Kneeshaw J, Tsui S, Dunning J, Wheaton E, Klein A, Arrowsmith J, Hall R, Jenkins D. Circulatory arrest versus cerebral perfusion during pulmonary endarterectomy surgery (PEACOG): a randomised controlled trial. Lancet 2011;378:1379-87.
38. Thistlethwaite PA, Kaneko K, Madani MM, Jamieson SW. Technique and outcomes of pulmonary endarterectomy surgery. Ann Thorac Cardiovasc Surg 2008;14:274-82.
39. Mayer, E, Jenkins, D, Lindner, J, D'Armini, A, Kloek, J, Meyns, B, Ilkjaer, LB, Klepetko, W, Delcroix, M, Lang, I, Pepke-Zaba, J, Simonneau, G, Dartevelle, P. Surgical management and outcome of patients with chronic thromboembolic pulmonary hypertension: Results from an international prospective registry J Thorac Cardiovasc Surg 2011;141:702-10.
40. Freed DH, Thomson BM, Berman M, et al. Survival after pulmonary thrombendarterectomy: Effect of residual pulmonary hypertension. J Thorac Cardiovasc Surg 2011;141:383-7.
41. Madani MM, Wittine LM, Auger WR, et al. Chronic thromboembolic pulmonary hypertension in pediatric patients. J Thorac Cardiovasc Surg 2011;141:624-30.
42. Jensen KW, Kerr KM, Fedullo PF, Kim NH, Test VJ, Ben-Yehuda O, Auger WR. Pulmonary hypertensive medical therapy in chronic thromboembolic pulmonary hypertension before pulmonary thromboendarterectomy. Circulation 2009;120:1248-54.
43. Hoeper MM, Barberà JA, Channick RN, Hassoun PM, Lang IM, Manes A, Martinez FJ, Naeije R, Olschewski H, Pepke-Zaba J, Redfield MM, Robbins IM, Souza R, Torbicki A, McGoon M. Diagnosis, assessment, and treatment of non-pulmonary arterial hypertension pulmonary hypertension. J Am Coll Cardiol 2009;54(Suppl 1):S85-96.